NCT00502203View on ClinicalTrials.gov

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Mixed Tumor, Mullerian
Interventions
DRUG

Carboplatin

AUC 5 By Vein Over 1 Hour Every 21 Days for 6 Courses

DRUG

Paclitaxel

175 mg/m\^2 By Vein Over 3 Hours Every 21 Days for 6 Courses

Trial Locations (4)

32806

MD Anderson Cancer Center, Orlando

77030

Lyndon Baines Johnson Hospital, Houston

UT MD Anderson Cancer Center, Houston

92354

Loma Linda Cancer Institute, Loma Linda

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00502203 - Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus | Biotech Hunter | Biotech Hunter